May 5, 2026 | Uncategorized
Key learnings include the latest PBM and policy developments, such as the ESI/FTC settlement, evolving pricing models, such as IRA Maximum Fair Prices, Most Favored Nations pricing, and direct-to-patient programs, payer management trends spanning biosimilars, medical...
Dec 10, 2025 | Uncategorized
Key learnings include: The latest IRA developments and other policy updates, including the OBBBA, MFN pricing, and ACIP disruptions, Emerging pricing and rebate models, including TrumpRx, direct-to-patient, and Cigna’s new rebate model, Payer management trends...
Apr 22, 2025 | Uncategorized
Key learnings include: Inflation Reduction Act Updates, Update on PBM-owned GPOs, including Synergie, 340B Developments, Biosimilars Update, including Private-Label Trends Payer Management Trends, Rare Disease Focus, and Highlights from HIRC’s Latest 2025...
Oct 17, 2024 | Uncategorized
Key learnings include: Key Payer & Provider Market Updates, Inflation Reduction Act – Changes to Part D Benefit Design & Payer Responses, Inflation Reduction Act – Negotiated Drug Prices & Payer Responses, Latest Trends in Payer Medication...
